abstraet
preliminari
studi
conduct
compar
region
intestin
immun
respons
neonat
calv
inocul
virul
attenu
bovin
coronaviru
bcv
determin
caus
report
vaccin
failur
group
newborn
colostrumdepriv
calv
use
two
calv
inocul
attenu
viru
four
calv
infect
virul
viru
includ
one
natur
infect
calf
three
calv
uninfect
control
calv
inocul
virul
viru
produc
higher
titer
bcv
antibodi
intestin
inocul
attenu
viru
failur
calv
respond
attenu
viru
appar
due
inabl
viru
replic
high
titer
spiral
colon
ileum
jejunum
found
immunolog
distinct
highest
antibcv
antibodi
respons
detect
spiral
colon
primari
site
infect
involv
four
isotyp
bovin
immunoglobulin
antibodi
respons
ileum
lower
spiral
colon
immun
respons
develop
slowli
jejunum
associ
primarili
lgg
subtyp
rrsumun
prrliminair
rralisd
pour
compar
local
la
rrpons
immunitair
au
niveau
intestin
de
veaux
nouveaunr
infectr
par
un
coronaviru
bovin
virul
ou
et
pour
ermin
le
caus
drchec
de
vaccin
un
group
de
neuf
veaux
nouveaunti
privr
de
colostrum
utilisr
deux
veaux
ont
infectr
par
un
viru
attrnur
quatr
par
un
viru
virul
incluant
un
veau
naturel
infectr
et
troi
non
infectd
servir
de
trmoin
le
veaux
inoculd
par
le
viru
virul
ont
produit
un
titr
en
anticorp
bcv
plu
import
au
niveau
de
lintestin
que
ceux
inoculr
par
le
viru
attrnur
la
diffrrenc
de
chez
le
veaux
inoculr
par
le
viru
sembl
due
du
viru
de
se
rrpliquer
de
haut
titr
le
colon
spiral
lileum
et
le
jejunum
ont
prrsentr
une
rrpons
immunologiqu
diffrrent
le
plu
haut
titr
danticorp
trouvr
dan
le
colon
spiral
site
primair
de
linfect
et
impliquai
quatr
isotyp
dimmunoglobulin
bovin
la
rrpons
immunitair
plu
faibl
dan
llileum
que
dan
le
colon
spiral
ell
sest
drveloppr
lentement
dan
le
jejenum
et
associr
primitiv
de
sou
type
dimmunoglobulin
g
bovin
coronaviru
bcv
import
caus
scour
neonat
calv
month
age
may
also
caus
pneumoenter
case
use
oral
attenu
viru
vaccin
report
ineffect
field
author
correspond
sanjay
kapil
et
al
experiment
situat
reason
vaccin
failur
known
may
attribut
unsuit
vaccin
lack
immun
respons
newborn
calv
sinc
mechan
respons
immun
protect
bcv
infect
known
evalu
vaccin
respons
difficult
intestin
immun
respons
appear
import
passiv
oral
transfer
monoclon
antibodi
found
offer
protect
bcv
infect
intestin
infect
rotaviru
infect
protect
correl
well
intestin
immun
serum
immun
differ
region
gut
may
differ
immun
respons
bcv
infect
viru
primarili
infect
spiral
colon
also
detect
intermitt
area
gut
eg
ileum
jejunum
saif
et
al
report
differ
level
viru
spiral
colon
ileum
jejunum
acut
bcv
infect
sinc
differ
region
intestin
variabl
level
involv
bcv
infect
necessari
evalu
region
immun
respons
bcv
isotypespecif
immun
respons
bcv
structur
protein
studi
present
studi
undertaken
evalu
antibcv
immun
respons
differ
region
intestin
week
old
calv
detail
experiment
anim
virus
use
studi
describ
earlier
briefli
nine
colostrumdepriv
unvaccin
male
holstein
calv
divid
three
group
inocul
oral
age
day
tissu
cultureadapt
attenu
bcv
mebu
strain
calv
virul
isol
bcv
calv
calf
natur
infect
calf
virusfre
diluent
calv
uninfect
control
right
flank
laparotomi
perform
prior
infect
weekli
interv
thereaft
collect
intestin
content
spiral
colon
ileum
jejunum
calf
oper
twice
third
sampl
obtain
euthanasia
schedul
stagger
cover
need
time
calv
group
calv
sedat
xylazin
hydrochlorid
rompun
mgkg
intraven
mgkg
intramuscularli
restrain
left
later
recumb
right
flank
clip
paralumbar
fossa
prepar
asept
surgeri
region
nerv
block
done
ml
lidocain
invert
l
pattern
cm
vertic
incis
made
midflank
muscl
layer
separ
grid
pattern
peritoneum
sharpli
incis
spiral
colon
ileum
jejunum
exterior
sampl
collect
order
collect
calv
occas
section
bowel
region
isol
digit
compress
ml
steril
salin
infus
isol
segment
immedi
aspir
via
enterocentesi
use
ml
syring
gaug
needl
flank
incis
close
routin
sanjay
kapil
et
al
manner
collect
sampl
transport
ice
laboratori
centrifug
min
supernat
store
polyclona
antisera
specif
bovin
immunoglobulin
class
iga
igm
subclass
refer
standard
colostr
serum
predetermin
amount
immunoglobulin
prepar
standard
curv
obtain
dr
han
fey
univers
bern
switzerland
highest
dilut
antisera
produc
clearli
visibl
precipit
ring
h
consid
optimum
incorpor
agaros
vv
iga
igm
respect
agaros
contain
antiserum
pour
glass
slide
x
cm
eastman
kodak
rochest
ny
sampl
well
mm
punch
pl
sampl
load
well
batteri
refer
standard
run
simultan
plate
plate
incub
humid
condit
h
diamet
precipit
ring
measur
use
hand
held
compar
measur
scale
confirm
precipit
ring
stain
amido
black
madin
darbi
bovin
kidney
mdbk
cell
infect
attenu
mebu
strain
bcv
place
slide
cell
line
associ
newfield
nj
use
cell
per
well
eagl
mem
contain
fetal
bovin
serum
incub
day
slide
wash
pb
ph
fix
cold
aceton
min
dri
store
use
dilut
pl
intestin
content
place
infect
fix
cell
follow
incub
h
humid
condit
wash
pb
ph
pl
rabbit
antibovin
fitc
conjug
ad
slide
incub
h
wash
pb
ph
counterstain
evan
blue
examin
fluoresc
microscop
antibodi
titer
sampl
consid
reciproc
highest
dilut
show
detect
fluoresc
microtit
plate
immunolon
dynatech
lab
alexandria
va
coat
ammonium
sulfat
precipit
monoclon
antibodi
bovin
igm
da
ng
iga
da
g
da
ng
da
g
dissolv
coat
buffer
carbonatebicarbon
ph
coat
overnight
plate
wash
time
elisa
buffer
pb
ph
unoccupi
site
block
casein
enzymat
hydrolys
ceh
h
humid
condit
elisa
procedur
sever
consecut
step
h
incub
humid
condit
step
wash
step
done
pb
contain
tween
ceh
sampl
dilut
prepar
pbscehtween
ad
appropri
well
follow
addit
bcv
second
site
antibodi
bcv
dilut
polyval
porcin
antibcv
ad
follow
addit
dilut
goat
antiporcin
igg
label
horseradish
peroxidas
color
develop
done
substrat
azinobisethylbenzthiazolinesulfon
acid
abt
min
reaction
stop
hydrofluor
acid
od
read
taken
sampl
consid
posit
ratio
sampl
neg
od
sn
isotypespecif
elisa
strong
posit
weak
posit
neg
control
includ
optimum
work
concentr
variou
reagent
captur
monoclon
antibodi
bovin
coronaviru
porcin
antibcv
antiserum
antiporcin
igg
conjug
determin
checkerboard
titrat
dilut
gave
highest
differ
posit
neg
control
use
specif
reactant
verifi
elimin
one
column
plate
thu
prevent
reaction
posit
control
sampl
dilut
run
triplic
evalu
region
antibcv
immun
respons
intestin
neonat
calv
quantit
srid
qualit
ifa
elisa
approach
use
basi
srid
test
igm
found
predomin
immunoglobulin
follow
iga
tabl
level
detect
limit
srid
virul
virusinfect
calv
total
antibcv
activ
intestin
secret
determin
ifa
calv
neg
day
age
viru
inocul
except
calf
natur
infect
calf
low
titer
calv
follow
inocul
attenu
viru
peak
titer
calf
antibodi
activ
could
detect
spiral
colon
fig
wherea
calf
detect
antibodi
activ
three
region
gut
ifa
titer
much
higher
calv
inocul
virul
viru
peak
titer
calv
respect
howev
calf
also
inocul
virul
viru
detect
antibodi
activ
ifa
region
intestin
uninfect
calv
alway
neg
ifa
calf
develop
natur
bcv
infect
also
produc
high
ifa
titer
antibodi
captur
elisa
done
determin
antibcv
activ
associ
differ
isotyp
bovin
immunoglobulin
calv
inocul
attenu
viru
igm
iga
respons
immedi
infect
develop
low
level
igm
igaassoci
antibcv
respons
week
infect
respect
fig
respons
could
detect
calv
fig
calv
inocul
virul
viru
calv
high
igm
iga
iggl
respons
fig
profil
develop
antibodi
respons
differ
calf
spiral
colon
calf
peak
igm
iga
titer
seen
day
postinfect
respect
igm
respons
ileum
develop
rapidli
persist
long
igm
iga
respons
seen
jejunum
calf
high
level
develop
rapidli
spiral
colon
calf
fig
appear
transient
ileum
jejunum
respons
develop
week
postinfect
calf
immun
respons
develop
slowli
three
region
gut
fig
peak
titer
seen
day
infect
natur
infect
calf
calf
igmassoci
respons
develop
igaassoci
respons
day
postinfect
spiral
colon
associ
antibcv
activ
calf
seen
earli
infect
spiral
colon
jejunum
ileum
respons
develop
ileum
later
calf
control
calv
neg
direct
posit
correl
elisa
ifa
titer
profil
similar
trend
test
differ
region
intestin
anatom
distinct
associ
lymphoid
compon
also
vari
consider
region
gut
isol
lymphocyt
lamina
propria
enterocyt
intraepitheli
lymphocyt
wherea
ileum
endow
distinct
lymphoid
nodul
call
peyer
patch
gastrointestin
tract
respons
foreign
antigen
includ
virus
probabl
larg
popul
macrophag
intestin
present
antigen
lymphocyt
level
bovin
immunoglobulin
igm
iga
differ
region
gut
estim
singl
radial
immunodiffus
predomin
immunoglobulin
igm
follow
iga
level
low
intestin
content
calv
lower
level
immunoglobulin
intestin
week
infect
virul
bcv
tabl
may
due
gener
immun
suppress
bcv
ifa
titer
calv
inocul
virul
viru
higher
inocul
attenu
viru
fig
probabl
virul
pneumoenter
viru
replic
much
higher
titer
attenu
viru
howev
calf
inocul
virul
viru
fail
develop
antibodi
bcv
develop
peracut
infect
die
level
intestin
immun
respons
found
directli
proport
rate
viru
multipl
amount
viral
antigen
bcvinfect
calv
presenc
higher
ifa
titer
spiral
colon
jejunum
ileum
surpris
spiral
colon
known
primari
site
bcv
multipl
antibcv
igm
iga
higher
spiral
colon
jejunum
ileum
fig
igaassoci
respons
develop
spiral
colon
calv
inocul
virul
viru
calf
develop
natur
infect
jejunum
immun
respons
associ
primarili
isotyp
develop
late
infect
profil
associ
antibcv
respons
similar
sinc
monoclon
antibodi
use
captur
antibodi
igg
subtyp
specif
cross
react
close
associ
respons
may
indic
intestin
antibodi
origin
serum
one
control
calv
calf
found
natur
infect
bcv
later
sanjay
kapil
et
al
studi
group
virul
virusinfect
group
sinc
calf
low
level
antibcv
ifa
antibodi
titer
day
age
specul
calf
either
acquir
infect
dam
parturit
acquir
matern
antibodi
due
leak
placent
barrier
normal
husbandri
condit
develop
activ
antibcv
immun
fece
influenc
passiv
deriv
colostr
antibodi
also
mucos
immun
respons
may
direct
whole
viru
subunit
bcv
data
suggest
newborn
calv
capabl
mount
intestin
immun
respons
vaccin
failur
probabl
result
overattenu
viru
also
differ
region
gut
immunolog
distinct
level
profil
anticoronaviru
antibodi
respons
associ
immunoglobulin
isotyp
differ
differ
interv
infect
cyclic
behavior
bcv
later
stage
infect
region
gut
may
relat
intestin
immun
respons
viru
may
present
particular
region
intestin
immun
low
part
gut
develop
intestin
immun
respons
immunoglobulin
class
switchov
rapid
system
respons
calv
inocul
virul
viru
similar
result
report
kimman
van
zaan
respiratori
tract
calv
inocul
bovin
respiratori
syncyti
viru
recogn
howev
preliminari
studi
employ
rel
small
number
anim
extens
studi
use
larg
number
anim
need
confirm
extend
result
studi
